Muse Bio

Muse.Bio

Employees
1–10
Business Model
B2B
Total Funding
$24.1M
Last Round
$1.1M Pre-SeedFeb 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Muse Bio turns menstrual blood, a renewable and overlooked biological resource, into a naturally derived, cell-free skincare ingredient produced to a documented quality standard. Founded by molecular biologist Juliette Humer, the company supplies a characterised conditioned media—available liquid or lyophilized—to skincare brands and formulators for serums, masks, and leave-on products. One hundred percent of net proceeds from the ingredient fund a separate women's-health research program. Muse Bio also runs a donor program that compensates contributors and includes STI screening, with the long-term mission of building the future of women's health on the most renewable biology in the human body.

Summary

Muse Bio is a Biotech company. It has raised $24.1M in total across 2 rounds, most recently a $1.1M Pre-Seed round in Feb 2025. Investors include Draper Associates, Venrock and Foresite Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BFeb 2025
$23.0M

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Muse Bio on Indexed.vc
<a href="https://indexed.vc/companies/muse-bio"><img src="https://indexed.vc/api/badge/company/muse-bio" alt="Muse Bio on Indexed.vc" width="260" height="76" /></a>